Optimizing intralesional triamcinolone acetonide treatment for isolated nail psoriasis: a pilot, intra-subject randomized controlled trial

Arch Dermatol Res. 2024 Mar 25;316(4):113. doi: 10.1007/s00403-024-02849-w.

Authors

Jose W Ricardo¹, Yuqing Qiu², Shari R Lipner³

Affiliations

¹ Department of Dermatology, Weill Cornell Medicine, New York, NY, United States.
² Department of Population Health Sciences, Weill Cornell Medicine, New York, NY, United States.
³ Department of Dermatology, Weill Cornell Medicine, New York, NY, United States. shl9032@med.cornell.edu.

PMID: 38526737
DOI: 10.1007/s00403-024-02849-w

No abstract available

Keywords: Intralesional; Nails; Psoriasis; Triamcinolone acetonide.

Publication types

Randomized Controlled Trial
Letter

MeSH terms

Humans
Injections, Intralesional
Nail Diseases* / drug therapy
Psoriasis* / drug therapy
Triamcinolone Acetonide / therapeutic use

Substances

Triamcinolone Acetonide